Eurofins Scientific, an international group of laboratories, agreed to acquire bioskin, an operator of a full-service, dermatology-specific CRO firm providing clinical trials for medicinal products and for medical devices. Financial terms were not disclosed. This acquisition, providing a range of complementary and extended services, supports Eurofins’ continued growth plans in these markets and further strengthens our offering to our customers and facilitates their one-stop access to multicentric studies.